Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

908 Devices (MASS) Other Accumulated Expenses (2020 - 2025)

908 Devices (MASS) has disclosed Other Accumulated Expenses for 6 consecutive years, with $691000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Other Accumulated Expenses rose 77.63% to $691000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $691000.0, a 77.63% increase, with the full-year FY2025 number at $691000.0, up 77.63% from a year prior.
  • Other Accumulated Expenses was $691000.0 for Q4 2025 at 908 Devices, up from $389000.0 in the prior quarter.
  • In the past five years, Other Accumulated Expenses ranged from a high of $1.4 million in Q4 2021 to a low of $125000.0 in Q1 2025.
  • A 5-year average of $715050.0 and a median of $702500.0 in 2023 define the central range for Other Accumulated Expenses.
  • Peak YoY movement for Other Accumulated Expenses: surged 125.85% in 2022, then crashed 78.15% in 2025.
  • 908 Devices' Other Accumulated Expenses stood at $1.4 million in 2021, then crashed by 35.18% to $899000.0 in 2022, then dropped by 20.24% to $717000.0 in 2023, then crashed by 45.75% to $389000.0 in 2024, then surged by 77.63% to $691000.0 in 2025.
  • Per Business Quant, the three most recent readings for MASS's Other Accumulated Expenses are $691000.0 (Q4 2025), $389000.0 (Q3 2025), and $374000.0 (Q2 2025).